Tissue-derived organoids are advanced 3D models created from adult patient biopsies or resected tissues, utilizing native LGR5+ stem cell populations for cultivation. These organoids closely mimic the physiological and molecular pathological characteristics of the original tissue, maintaining high genetic stability and mature phenotypic features. Unlike iPSC-derived organoids, tissue-derived models reflect the true physiological environment during long-term cultivation. While initially derived from primary tissues, they do not require new tissue for ongoing experiments, making them ideal for sustained organ culture models without the need for fresh tissue acquisition. This offers significant advantages for disease modeling, drug testing, and regenerative research. Organoids undergo rigorous testing for mycoplasma, bacteria, fungi/yeast, and are verified for identity, genetic stability, and functional performance, ensuring high reliability for research and clinical applications.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Tissue-derived organoids are widely used in drug screening, disease modeling, mechanism research, personalized medicine, and regenerative medicine. By simulating authentic disease states, these organoids provide an ideal platform to assess patient responses to new drugs and assist in the design of personalized treatment plans. Additionally, they drive the development of new therapeutic approaches, particularly in cancer research and organ regeneration, offering precise experimental tools that greatly enhance the advancement of precision medicine.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.